Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
21.02
Dollar change
+0.51
Percentage change
2.49
%
IndexNDX, S&P 500 P/E31.61 EPS (ttm)0.66 Insider Own17.51% Shs Outstand863.67M Perf Week-0.33%
Market Cap18.13B Forward P/E6.01 EPS next Y3.50 Insider Trans-0.00% Shs Float711.34M Perf Month-2.82%
Income574.00M PEG- EPS next Q0.82 Inst Own59.65% Short Float4.38% Perf Quarter-21.01%
Sales142.41B P/S0.13 EPS this Y-18.70% Inst Trans-0.06% Short Ratio2.31 Perf Half Y-0.52%
Book/sh22.60 P/B0.93 EPS next Y8.07% ROA0.60% Short Interest31.16M Perf Year-36.19%
Cash/sh0.91 P/C23.12 EPS next 5Y-5.02% ROE2.86% 52W Range19.68 - 36.58 Perf YTD-19.49%
Dividend Est.1.45 (6.90%) P/FCF- EPS past 5Y- ROI1.15% 52W High-42.54% Beta0.72
Dividend TTM1.69 (8.04%) Quick Ratio0.30 Sales past 5Y1.35% Gross Margin17.21% 52W Low6.79% ATR (14)0.57
Dividend Ex-DateFeb 16, 2024 Current Ratio0.66 EPS Y/Y TTM119.40% Oper. Margin1.29% RSI (14)47.87 Volatility2.21% 2.59%
Employees331000 Debt/Eq1.78 Sales Y/Y TTM7.73% Profit Margin0.40% Recom3.10 Target Price24.88
Option/ShortYes / Yes LT Debt/Eq1.57 EPS Q/Q98.20% Payout- Rel Volume0.92 Prev Close20.51
Sales Surprise5.03% EPS Surprise7.16% Sales Q/Q9.96% EarningsMar 28 BMO Avg Volume13.50M Price21.02
SMA200.38% SMA50-3.42% SMA200-13.51% Trades Volume12,394,434 Change2.49%
Date Action Analyst Rating Change Price Target Change
Feb-26-24Initiated Leerink Partners Market Perform $23
Feb-20-24Downgrade HSBC Securities Hold → Reduce
Jan-03-24Initiated Barclays Underweight $21
Dec-22-23Initiated HSBC Securities Hold $27
Oct-23-23Upgrade JP Morgan Neutral → Overweight $27 → $30
Jul-03-23Reiterated Morgan Stanley Underweight $37 → $27
Jun-28-23Downgrade Deutsche Bank Buy → Hold $46 → $34
Feb-23-23Initiated Loop Capital Buy $45
Nov-23-22Resumed Morgan Stanley Underweight $39
Nov-22-22Upgrade Cowen Market Perform → Outperform $43 → $54
Today 05:18AM
05:16AM
Mar-27-24 05:05PM
04:30PM
Mar-26-24 11:18AM
10:35AM Loading…
10:35AM
06:05AM
Mar-25-24 12:09PM
11:26AM
09:15AM
Mar-24-24 02:00PM
10:58AM
07:56AM
Mar-23-24 05:43AM
Mar-22-24 05:45PM
04:31PM Loading…
04:31PM
07:37AM
Mar-21-24 05:50PM
12:37PM
10:00AM
08:30AM
06:16AM
Mar-20-24 01:23PM
08:15AM
Mar-18-24 06:00AM
05:55AM
01:00AM
Mar-15-24 05:45PM
10:05AM
Mar-14-24 01:41PM
09:26AM Loading…
09:26AM
09:00AM
Mar-13-24 01:15PM
08:37AM
06:00AM
Mar-12-24 05:50PM
03:31PM
12:15PM
09:26AM
08:30AM
Mar-11-24 07:03PM
05:51PM
05:39PM
12:14PM
Mar-10-24 07:10PM
06:44AM
Mar-09-24 12:14PM
Mar-08-24 12:30PM
11:30AM
03:13AM
Mar-07-24 12:28PM
12:25PM
Mar-06-24 05:45PM
Mar-04-24 11:37AM
11:10AM
10:00AM
09:51AM
09:42AM
09:30AM
08:26AM
03:58AM
Mar-01-24 04:27PM
01:28PM
01:09PM
11:40AM
11:36AM
11:27AM
11:12AM
03:48AM
Feb-29-24 10:05PM
07:41PM
05:45PM
11:15AM
09:19AM
Feb-28-24 09:00AM
Feb-27-24 06:48PM
05:50PM
11:27AM
Feb-26-24 04:05PM
11:41AM
10:59AM
09:57AM
09:45AM
09:33AM
08:30AM
Feb-24-24 07:55AM
Feb-23-24 05:21AM
01:59AM
Feb-22-24 08:31PM
05:45PM
03:15PM
03:55AM
Feb-21-24 04:22PM
04:06PM
02:33PM
02:33PM
01:00PM
12:04PM
10:40AM
10:12AM
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walgreens Boots Alliance, Inc.10% OwnerFeb 07 '24Sale235.414,212,395991,639,90726,277,561Feb 09 07:00 AM
JARRETT VALERIE BDirectorJan 29 '24Buy22.444,45699,9934,456Jan 31 04:11 PM
SCHLICHTING NANCY MDirectorJan 16 '24Sale23.0515,209350,5670Jan 18 04:18 PM
WENTWORTH TIMOTHY CChief Executive OfficerJan 05 '24Buy24.2210,000242,220585,122Jan 08 07:29 AM
Gates Richard P.SVP, Chief Pharmacy OfficerNov 10 '23Sale20.451,00020,45073,929Nov 14 08:22 PM
Walgreens Boots Alliance, Inc.10% OwnerNov 09 '23Sale195.381,279,590249,999,89630,489,956Nov 14 07:15 AM
Walgreens Boots Alliance, Inc.10% OwnerAug 03 '23Sale189.271,320,858250,000,11531,769,546Aug 07 05:48 PM
DRISCOLL JOHN PATRICKEVP, Pres. U.S. HealthcareJun 30 '23Buy28.425,172146,98459,050Jul 05 06:57 PM
Walgreens Boots Alliance, Inc.10% OwnerJun 15 '23Sale181.17275,98450,000,02133,090,404Jun 20 06:03 AM
Walgreens Boots Alliance, Inc.10% OwnerMay 11 '23Sale170.77292,79250,000,09033,366,388May 15 05:18 PM
BREWER ROSALIND GCEOMar 29 '23Buy33.9510,000339,510369,945Mar 31 04:26 PM